Results of the fifth scientific workshop of the ECCO (II): pathophysiology of perianal fistulizing disease

B Siegmund, RM Feakins, G Bamias… - Journal of Crohn's …, 2016 - academic.oup.com
The fifth scientific workshop of the European Crohn's and Colitis Organization (ECCO)
focused on the relevance of fistulas to the disease course of patients with Crohn's disease …

Cytokine and anti-cytokine therapies in prevention or treatment of fibrosis in IBD

N Jacob, SR Targan, DQ Shih - United European …, 2016 - journals.sagepub.com
The frequency of fibrosing Crohn's disease (CD) is significant, with approximately 40% of
CD patients with ileal disease developing clinically apparent strictures throughout their …

Protective effect of infliximab, a tumor necrosis factor-alfa inhibitor, on bleomycin-induced lung fibrosis in rats

N Altintas, M Erboga, C Aktas, B Bilir, M Aydin… - Inflammation, 2016 - Springer
We aimed to investigate the preventive effect of Infliximab (IFX), a tumor necrosis factor
(TNF)-α inhibitor, on bleomycin (BLC)-induced lung fibrosis in rats. Rats were assigned into …

Idiopathic pulmonary fibrosis

JP Lynch, RS Mahidhara… - Interstitial Pulmonary …, 2016 - api.taylorfrancis.com
Idiopathic pulmonary fibrosis (IPF) is a distinct clinical syndrome of unknowncause
characterized by progressive dyspnea, dry cough, basilar crackles, arestrictive ventilatory …

结缔组织病相关间质性肺疾病诊治进展

李娜, 张彦萍 - 临床荟萃, 2016 - huicui.hebmu.edu.cn
结缔组织病相关间质性肺疾病诊治进展 首页 杂志介绍 编委会 投稿指南 期刊浏览 最新录用 当期
目录 过刊浏览 阅读排行 下载排行 引用排行 期刊订阅 广告合作 联系我们 English 临床荟萃 • 专题 …

Connective-Tissue Disease-Associated Interstitial Lung Disease

H Nunes, Y Uzunhan, D Valeyre… - Interstitial …, 2016 - api.taylorfrancis.com
The connective tissue diseases (CTDs) are a heterogeneous group of immuno-logically
mediated inflammatory conditions of unknown etiology, accompaniedby diverse …

[PDF][PDF] Biologic treatments for pulmonary involvment in rheumatic disease

HS Garthwaite, JC Porter - 2016 - discovery.ucl.ac.uk
Interstitial lung disease (ILD) is a common complication of many autoimmune rheumatic
diseases and has significant morbidity and mortality implications. Despite this, there is a lack …

Immunosuppressive and Cytotoxic Drug Therapy for Diffuse ILD

RP Baughman, EE Lower - Interstitial Pulmonary and …, 2016 - api.taylorfrancis.com
Over the past 15 years there has been a palpable shift in the use of various agentsin the
treatment of diffuse interstitial lung diseases (ILDs). The original treat-ments focused on …

Μελέτη του πνευμονικού παρεγχύματος με υπολογιστική τομογραφία θώρακος υψηλής ευκρίνειας σε ασθενείς με ρευματοειδή αρθρίτιδα πριν και μετά τη θεραπεία με …

Ε Δετοράκης - 2016 - didaktorika.gr
Περίληψη Μελέτη του πνευμονικού παρεγχύματος με υπολογιστική τομογραφία θώρακος
υψηλής ευκρίνειας (HRCT) σε ασθενείς με ρευματοειδή αρθρίτιδα πρίν και μετά την θεραπεία …